The results suggest that in routine fatty liver screening and diagnosis, clinical sonographers could incorporate patients’ serum insulin levels as an auxiliary reference marker to facilitate earlier metabolic risk assessment and intervention for individuals with suspicious imaging findings. Here, INS is linked to fatty liver disease.